A Crossover Study of Clocapramine and Haloperidol in Chronic Schizophrenia

  title={A Crossover Study of Clocapramine and Haloperidol in Chronic Schizophrenia},
  author={S. Yamagami},
  journal={Journal of International Medical Research},
  pages={301 - 310}
  • S. Yamagami
  • Published 1985
  • Medicine
  • Journal of International Medical Research
Therapeutic efficacy and target symptoms with clocapramine were compared with those with haloperidol by the crossover method, in a total of 26 chronic schizophrenic patients, by administration of one of the drugs for the first 14 weeks and the other for the next 14 weeks. The final global improvement rating showed no significant difference between the two groups, but clocapramine administered as first drug appeared to have a more pronounced effect than haloperidol. According to the improvement… Expand
3 Citations
Sulpiride for schizophrenia.
Augmentation of paroxetine with clocapramine in panic disorder


Comparison of Efficacy of Timiperone, a New Butyrophenone Derivative, and Clocapramine in Schizophrenia: A Multiclinic Double-Blind Study
High-dose propranolol in schizophrenia.
  • G. Sheppard
  • Medicine
  • The British journal of psychiatry : the journal of mental science
  • 1979
A study on the pharmacological and biochemical profile of clocapramine.
Impact of neuroleptic chemotherapies on schizophrenic psychoses.
  • P. Deniker
  • Psychology, Medicine
  • The American journal of psychiatry
  • 1978
Molecular pathology of schizophrenia: more than one disease process?
  • T. Crow
  • Medicine
  • British medical journal
  • 1980
A standardized psychiatric assessment scale for rating chronic psychotic patients
Clinical evaluation of a new-psychotropic drug, Y-4153: comparative study with chlorpromazine using the double-blind method
  • ofInternational Medical Research 11,
  • 1972